Used in peptide synthesis as a chiral building block for introducing a 4-methoxyphenyl-modified amino acid residue. The Fmoc group enables solid-phase synthesis by allowing stepwise assembly of peptides with orthogonal protection. The aromatic side chain can influence peptide conformation and stability, and may enhance interactions in bioactive peptides. Commonly applied in the development of enzyme inhibitors, receptor ligands, and structured peptides where steric and electronic effects of the methoxyphenyl group play a role in activity. Suitable for synthesizing analogs in structure-activity relationship (SAR) studies.